Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 7,500 shares at $0.29 ($2K) on 2019-08-26, disclosed to the SEC on 2019-08-28.
Open-market purchase of $2k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 4,000 | $1K | 49.6% |
| 2 | $0.29 | 3,500 | $1K | 50.4% |
| Total | $0.27 avg | 7,500 | $2K | 100% |
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |